CorMedix Inc.
CRMD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001410098
No open-market purchases or sales by CorMedix Inc. insiders were filed in the last 90 days; 193 institutions reported holding it in 13F filings for Q2 2026, worth $345.5M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in CorMedix Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 190
- +18 vs. Q2 2025
- Shares held
- 43.1M
- +8.96M (+26.2%) vs. Q2 2025
- Total value
- $501.5M
- +$80.7M (+19.2%) vs. Q2 2025
- New holders
- 51
- 91 more added
- Sold out
- 33
- 28 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CRMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 193 | $345.5M |
| Q1 2026 | 188 | $279.8M |
| Q4 2025 | 200 | $488.3M |
| Q3 2025 | 190 | $501.5M |
| Q2 2025 | 172 | $420.8M |
| Q1 2025 | 136 | $144.9M |
| Q4 2024 | 129 | $186.1M |
| Q3 2024 | 102 | $154.7M |
| Q2 2024 | 99 | $74.3M |
| Q1 2024 | 90 | $73.2M |
| Q4 2023 | 101 | $70.5M |
| Q3 2023 | 92 | $66.2M |
| Q2 2023 | 86 | $76.1M |
| Q1 2023 | 66 | $44.7M |
| Q4 2022 | 66 | $47.1M |
| Q3 2022 | 73 | $31.3M |
| Q2 2022 | 74 | $49.4M |
| Q1 2022 | 85 | $73.4M |
| Q4 2021 | 80 | $59.4M |
| Q3 2021 | 79 | $55.0M |
| Q2 2021 | 79 | $78.0M |
| Q1 2021 | 79 | $107.6M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding CorMedix Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −152,200−100.0% | Sold out |
| Militia Capital Partners, LP | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −62,549−100.0% | Sold out |
| Panoramic Capital, LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −36,665−100.0% | Sold out |
| Mach-1 Financial Group, Inc. | 0 | $0 | 0.00% | −29,661−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −28,039−100.0% | Sold out |
| Beacon Pointe Advisors, LLC | 0 | $0 | 0.00% | −24,000−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −23,428−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −23,056−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −22,708−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −19,683−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −15,241−100.0% | Sold out |
| Entropy Technologies, LP | 0 | $0 | 0.00% | −11,297−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −11,110−100.0% | Sold out |
| Kapitalo Investimentos Ltda | 0 | $0 | 0.00% | −10,016−100.0% | Sold out |
| ARS Wealth Advisors Group, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| USA Financial Portformulas Corp | 0 | $0 | 0.00% | −4,461−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −2,985−100.0% | Sold out |
| Thurston, Springer, Miller, Herd & Titak, Inc. | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Essential Partners LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −9−100.0% | Sold out |